| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥4.4B | - | - |
| Operating Income | ¥-0.4B | - | - |
| Ordinary Income | ¥-0.5B | - | - |
| Net Income | ¥-0.5B | - | - |
| ROE | -4.8% | - | - |
FY2026 Q1 results: Revenue 4.4B yen, Operating Income -0.4B yen (operating loss), Ordinary Income -0.5B yen (ordinary loss), Net Income -0.5B yen (net loss). The company recorded losses across all profit levels with EPS of -45.47 yen. Despite maintaining a gross profit margin of 34.1%, SG&A expenses of 1.9B yen (43.9% of revenue) drove the operating loss. Total assets stand at 16.2B yen with a healthy cash position of 10.8B yen, representing 66.7% of total assets. The equity ratio remains solid at 68.0%, though ROE is negative at -4.8%. Two subsidiaries were newly consolidated during the quarter, generating goodwill of approximately 86M yen.
Revenue for the quarter reached 4.4B yen, comprised primarily of IT Sales Outsourcing (3.9B yen) and Healthcare Business (0.5B yen) segments. The IT Sales Outsourcing segment includes three sub-businesses: Sales Outsourcing (279M yen), Solution Business (56M yen), and Engineering Business (50M yen). The Healthcare segment consists of Healthcare Support (43M yen) and Nursing Recreation (6M yen). Qualitative segment notes indicate that Good Digital Co., Ltd., previously an unconsolidated subsidiary, was consolidated during Q1 after acquiring importance through the system engineering service business transfer from DXO Corporation, generating goodwill of 76M yen. Additionally, Robotas Net Co., Ltd. was newly acquired and consolidated, contributing goodwill of 10M yen. These consolidations expanded the revenue base but also increased corporate-wide expenses.
From a profitability perspective, gross profit of 1.5B yen delivered a 34.1% margin, indicating reasonable pricing power or operational efficiency at the direct cost level. However, SG&A expenses of 1.9B yen overwhelmed gross profit, resulting in an operating loss of 0.4B yen (operating margin of -9.8%). Corporate headquarters costs not allocated to segments totaled 62M yen according to segment footnotes, contributing to the elevated SG&A burden. Non-operating expenses of 0.1B yen, primarily commission fees, expanded the ordinary loss to 0.5B yen. Income tax expense was minimal at 0.0B yen due to the pre-tax loss, resulting in net loss of 0.5B yen. No material extraordinary items such as impairment losses were recorded. The performance pattern reflects revenue generation with profit deterioration, specifically a loss situation where gross margin is positive but operating-level profitability cannot be achieved due to structural cost burden.
The IT Sales Outsourcing segment generated revenue of 3.9B yen with operating income of 0.4B yen, yielding a segment margin of 9.9%. This represents the core business, accounting for approximately 88% of total revenue. The segment demonstrated profitability at the operating level, indicating its role as the earnings foundation. In contrast, the Healthcare Business segment recorded revenue of 0.5B yen with an operating loss of 0.0B yen (margin of -8.4%), reflecting negative profitability. Corporate and other operations recorded a segment loss of 0.2B yen. After corporate-wide cost allocation of 0.1B yen (primarily unallocated general and administrative expenses of 62M yen), consolidated operating income reached -0.4B yen. The profitability gap between segments is material, with IT Sales Outsourcing maintaining positive margins while Healthcare remains unprofitable. The consolidation of new subsidiaries within IT Sales Outsourcing contributed to both revenue expansion and goodwill recognition, warranting monitoring of integration synergies and potential impairment risks.
[Profitability] ROE of -4.8% reflects the net loss position, with operating margin at -9.8% and net profit margin at -12.1%. The DuPont decomposition shows ROE = net margin (-12.1%) × asset turnover (0.270) × financial leverage (1.47), indicating profitability deterioration as the primary driver of negative ROE. Gross profit margin of 34.1% suggests pricing discipline or operational efficiency at the direct cost level, but SG&A ratio of 43.9% overwhelms this, resulting in operating-level losses. ROIC stands at -24.6%, indicating capital is not generating positive returns. [Cash Quality] Cash and deposits of 10.8B yen provide strong liquidity coverage at 2.9x short-term debt obligations. Days Sales Outstanding (DSO) of 169 days and Cash Conversion Cycle (CCC) of 153 days indicate extended working capital cycles, suggesting slower receivables collection and cash realization despite the substantial cash balance. [Investment Efficiency] Asset turnover of 0.270 is below the industry median of 0.18, though the quarterly revenue base makes direct comparison difficult. The extended operating cycle (DSO 169 days) constrains asset efficiency. [Financial Health] Equity ratio of 68.0% exceeds the industry median of 68.9%, demonstrating solid capital adequacy. Current ratio of 371.6% and quick ratio of 367.0% reflect substantial liquidity cushion. Debt-to-equity ratio of 0.47 and Debt-to-Capital ratio of 12.0% indicate conservative financial leverage with long-term loans of 1.5B yen representing the primary borrowing. Interest coverage is negative at -64.28x due to negative EBIT, warranting attention despite minimal interest expense of 0.0B yen.
Cash and deposits increased to 10.8B yen, representing 66.7% of total assets and providing substantial liquidity buffer. The current ratio of 371.6% indicates cash coverage of short-term liabilities at 2.9x, demonstrating adequate short-term solvency. Trade receivables of 2.0B yen relative to quarterly revenue of 4.4B yen imply DSO of 169 days, indicating extended collection periods that delay cash conversion despite operating activities. Inventories remain minimal at 0.2B yen, suggesting asset-light operations or service-oriented business model. Trade payables of 0.3B yen are modest relative to cost of sales of 2.9B yen, indicating limited supplier credit utilization. The working capital composition shows concentration in receivables rather than inventory, with CCC of 153 days reflecting the collection-driven operating cycle. Long-term loans of 1.5B yen represent the primary debt obligation, with interest expense of 0.0B yen indicating manageable debt servicing. The balance sheet structure suggests cash accumulation from prior periods or equity financing rather than current period operating cash generation, given the net loss of 0.5B yen. The consolidation of two subsidiaries during the quarter added intangible assets including goodwill of approximately 86M yen, representing investing activity through business combinations.
Ordinary income of -0.5B yen versus operating income of -0.4B yen indicates non-operating net expense of approximately 0.1B yen, primarily comprising commission fees. Non-operating income of 0.0B yen included minimal partnership gains, while non-operating expenses totaled 0.1B yen with interest expense of 0.0B yen and commission fees of 0.1B yen. Non-operating items represent approximately 2% of revenue, a relatively modest impact on overall profitability structure. The alignment between operating loss and ordinary loss suggests core business operations drive the loss position without material distortion from financial activities. The minimal gap between ordinary income and net income (-0.5B yen vs -0.5B yen) reflects negligible tax expense due to the pre-tax loss position. No extraordinary items such as asset sales, restructuring costs, or impairment losses were recorded, confirming the loss stems from recurring operations. While cash flow statement data is unavailable for quarterly reporting, the extended DSO of 169 days and CCC of 153 days suggest potential working capital-related cash consumption despite the strong cash position. The accumulation of goodwill (86M yen from two acquisitions during Q1) represents non-cash investment activity that will generate future amortization expenses, adding to SG&A burden. The provisional nature of goodwill allocation noted in segment disclosures indicates potential future adjustments. Earnings quality is constrained by operating-level losses and extended working capital cycles, though the absence of non-recurring items provides clarity on underlying business performance.
The company maintains full-year guidance of Revenue 18.5B yen, Operating Income -1.9B yen (operating loss), Ordinary Income -1.9B yen (ordinary loss), and EPS of -33.51 yen with dividend forecast of 0.00 yen. Q1 revenue of 4.4B yen represents 23.8% progress toward the 18.5B yen full-year target, slightly below the standard quarterly rate of 25%. Q1 operating loss of 0.4B yen represents 21.1% of the forecasted full-year operating loss of 1.9B yen, suggesting the loss trajectory is tracking below full-year expectations but remains on a loss path. The negative progress rate indicates potential for smaller full-year losses if operational improvements materialize in subsequent quarters, though guidance has not been revised. Forecast assumptions from available notes indicate continued consolidation effects from newly acquired subsidiaries and corporate cost structure carrying forward. The full-year operating loss guidance of -1.9B yen implies an average quarterly operating loss of 0.5B yen, with Q1 actual of -0.4B yen tracking slightly better. However, achieving profitability improvement requires substantial SG&A reduction or revenue acceleration beyond current trajectory. The forecast EPS of -33.51 yen compares to Q1 actual EPS of -45.47 yen, suggesting either Q1 loss concentration or need for guidance reassessment. No specific disclosure of guidance revision drivers or operational assumptions is available in the quarterly report.
The company forecasts annual dividend of 0.00 yen with no interim or year-end dividends planned. This represents continuation of zero payout policy given the loss position. Payout ratio is not applicable due to negative net income. No share buyback activities are disclosed for the quarter. Total return ratio (dividends plus buybacks relative to net income) is not calculable given zero shareholder distributions and negative earnings. The zero dividend policy reflects prioritization of cash preservation and financial stability over shareholder distributions during the loss period. With cash and deposits of 10.8B yen against net loss of 0.5B yen, the company maintains substantial liquidity buffer, though dividend resumption would require return to sustainable profitability rather than merely adequate cash reserves. The absence of shareholder returns aligns with conservative financial management given negative ROE of -4.8% and operating losses, directing available resources toward operational recovery and potential growth investments including the two subsidiary acquisitions completed during Q1.
Integration and goodwill risks from new consolidations: The Q1 consolidation of Good Digital Co., Ltd. and Robotas Net Co., Ltd. generated goodwill of approximately 86M yen with provisional allocation pending finalization. If integration synergies fail to materialize or acquired operations underperform, impairment losses could emerge, further pressuring profitability. The Healthcare segment's operating loss of -0.0B yen (-8.4% margin) including newly acquired Robotas Net suggests integration challenges may already be present.
Working capital efficiency deterioration: DSO of 169 days and CCC of 153 days indicate extended cash conversion cycles well above typical service industry standards. This ties up capital in receivables (2.0B yen) and delays cash realization, potentially requiring additional financing or constraining growth investments if collection performance does not improve. The quality alerts flag this as a significant operational risk affecting cash flow volatility.
Structural profitability challenges: SG&A expenses of 1.9B yen (43.9% of revenue) exceed gross profit of 1.5B yen (34.1% margin), creating inherent operating losses at the current revenue scale. Corporate headquarters costs of 62M yen not allocated to segments add fixed cost burden. Without substantial revenue scaling or cost restructuring, achieving sustainable operating profitability remains uncertain. EBIT margin of -9.8% and ROIC of -24.6% quantify the severity of capital inefficiency, while negative interest coverage (-64.28x) highlights vulnerability to any debt servicing increase despite currently minimal interest expense of 0.0B yen.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: Operating margin of -9.8% significantly underperforms the IT & Telecom industry median of 5.3% (IQR: 3.0%-26.3%), placing the company below the 25th percentile. Net profit margin of -12.1% contrasts sharply with industry median of 0.6% (IQR: 0.5%-16.6%), indicating material profitability disadvantage. ROE of -4.8% substantially trails industry median of 0.2% (IQR: 0.1%-2.3%). ROIC of -24.6% versus industry median of 0.01 demonstrates severe capital efficiency underperformance.
Financial Health: Equity ratio of 68.0% aligns closely with industry median of 68.9% (IQR: 64.1%-79.9%), indicating comparable capital structure conservatism. Financial leverage of 1.47x matches industry median of 1.45 (IQR: 1.28-1.49), reflecting similar debt utilization levels despite profitability differences.
Efficiency: Asset turnover of 0.270 exceeds industry median of 0.18 (IQR: 0.15-0.19), suggesting relatively stronger asset utilization despite working capital cycle concerns. However, this advantage does not translate to profitability given the negative operating margins.
Growth: Revenue growth assessment requires prior period comparison unavailable in current data. Industry median revenue growth YoY of 25.5% (IQR: 20.9%-26.2%) and EPS growth median of 0.03 (IQR: -0.18-0.12) provide context, though the company's negative earnings position limits direct EPS growth comparability.
The company's primary competitive disadvantage lies in profitability metrics, with operating and net margins substantially below industry standards despite comparable financial leverage and equity positioning. Capital efficiency as measured by ROIC represents the most severe underperformance area, suggesting operational model challenges beyond typical industry dynamics.
(Industry: IT & Telecom, 3 companies, Comparison: 2025-Q1 median, Source: Proprietary analysis)
Structural profitability challenge requiring operational transformation: The company faces fundamental profitability issues with SG&A expenses (1.9B yen, 43.9% of revenue) exceeding gross profit (1.5B yen, 34.1% margin), resulting in operating losses across recent periods. Operating margin of -9.8% substantially underperforms industry median of 5.3%, indicating competitive disadvantage beyond cyclical factors. The full-year guidance projecting continued operating losses (-1.9B yen) confirms management expects near-term continuation of this pattern. Achieving sustainable profitability requires either substantial revenue scaling to leverage fixed costs or significant cost structure reduction, neither of which is explicitly guided.
Strong financial flexibility provides time for turnaround execution: Despite operating losses, the company maintains exceptional liquidity with cash of 10.8B yen (66.7% of assets), current ratio of 371.6%, and conservative leverage (equity ratio 68.0%, debt-to-equity 0.47). This financial cushion provides runway to execute operational improvements without immediate solvency pressure. However, working capital efficiency concerns (DSO 169 days, CCC 153 days) suggest cash generation capability is constrained, making the existing cash stockpile a non-renewable buffer unless operational cash flow improves.
M&A integration and goodwill risks require monitoring: The Q1 consolidation of two subsidiaries generated provisional goodwill of 86M yen, representing 5.3% of total assets and 7.8% of equity. The Healthcare segment's operating loss (-8.4% margin) including newly acquired Robotas Net indicates integration challenges may already be materializing. Management notes the goodwill allocation remains provisional pending final purchase price allocation, creating uncertainty around ultimate accounting impact. If acquired operations fail to achieve profitability or generate expected synergies, impairment charges could emerge, further eroding equity. Given negative ROIC of -24.6%, capital allocation effectiveness warrants close scrutiny, particularly for growth-through-acquisition strategies.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.